In Canada, the last distribution of this product to pharmaceutical distributors is expected to take place in June 2023.
Baqsimi® glucagon nasal spray remains available for children four years of age and older.
For individuals for whom injectable glucagon remains the medication indicated for severe hypoglycemia, please note that NovoNordisk continues to produce and distribute Glucagen® (injectable glucagon).
For more details, please see the Eli Lilly press release or contact their customer service department at 1-888-545-5972.